Point72 Asset Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
OAM
HRCM
FAM
GS
Point72 Asset Management's CDNA Position: Q1 2025 in Review
Point72 Asset Management sold out of CareDx (CDNA) in Q1 2025, closing a stake of 465,665 shares — an estimated $9.97M sold.
Point72 Asset Management first reported a position in CDNA in Q2 2018 and held it in 17 quarters. The position peaked at $28.6M in Q3 2020. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.
- Point72 Asset Management reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
- Point72 Asset Management sold 465,665 CareDx shares in Q1 2025, an estimated $9.97M.
- Point72 Asset Management first reported a position in CareDx in Q2 2018 and held it in 17 quarters.
- Point72 Asset Management's CareDx position peaked at $28.6M in Q3 2020.
- 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.
Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.